NR
AGN

Newfound Research’s Allergan plc AGN Stock Holding History

Newfound Research’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed – – 206
2020
Q1 		$0 Hold
1
– – ﹤0.01% 222
2019
Q4 		$0 Buy
+1
New +$180 ﹤0.01% 234
2019
Q2 		– Sell
-1
Closed – – 231
2019
Q1 		$0 Buy
+1
New +$145 ﹤0.01% 241

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Newfound Research's AGN Position: Q2 2020 in Review

Newfound Research sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1 share.

Newfound Research first reported a position in AGN in Q1 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Newfound Research reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Newfound Research sold 1 Allergan plc share in Q2 2020.
  • Newfound Research first reported a position in Allergan plc in Q1 2019 and held it in 3 quarters.
  • Newfound Research's Allergan plc position peaked at $0 in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.